Karyopharm Therapeutics Inc.

KPTI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$33-$37-$23-$31
Dep. & Amort.$0-$0$0$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$4$4$4
Change in WC$0$10-$2$10
Other Non-Cash$33$5-$18-$11
Operating Cash Flow$0-$19-$39-$26
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$18$15$0
Other Inv. Act.$0$0$0$15
Investing Cash Flow$0$18$15$15
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$1
Financing Cash Flow$0$0$0$1
Forex Effect$0$0$0-$0
Net Chg. in Cash-$39-$0-$24-$10
Supplemental Information
Beg. Cash$39$39$63$73
End Cash$0$39$39$63
Free Cash Flow$0-$19-$39-$26
Karyopharm Therapeutics Inc. (KPTI) Financial Statements & Key Stats | AlphaPilot